Drug Delivery Systems (trends) < Drug Design < Drug Development

Facettes : AffPays.f Mesh.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 31.
[0-20] [0 - 20][0 - 31][20-30][20-40]

Ident.	Authors (with country if any)	Title
000012 (1998)	G J Hanson [États-Unis]	DR (MHC class II) ligands: an approach to rheumatoid arthritis therapeutics.
000055 (1999)	S M Gryaznov [États-Unis]	Oligonucleotide N3'-->P5' phosphoramidates as potential therapeutic agents.
000103 (????)	V. Theodorou [Grèce] ; V. Tsikaris ; M. Sakarellos-Daitsiotis ; V. Avramopoulou ; K. Kostelidou ; S J Tzartos ; C. Sakarellos	Design, synthesis, and conformational study of biologically active photolabeled analogues of the main immunogenic region of the acetylcholine receptor.
000126 (2001)	K H Mayo [États-Unis] ; D W Van Der Schaft ; A W Griffioen	Designed beta-sheet peptides that inhibit proliferation and induce apoptosis in endothelial cells.
000160 (2002)	Tami L. Raguse [États-Unis] ; Emilie A. Porter ; Bernard Weisblum ; Samuel H. Gellman	Structure-activity studies of 14-helical antimicrobial beta-peptides: probing the relationship between conformational stability and antimicrobial potency.
000326 (2005)	Joel N H. Stern [États-Unis] ; Zsolt Illés ; Jayagopala Reddy ; Derin B. Keskin ; Masha Fridkis-Hareli ; Vijay K. Kuchroo ; Jack L. Strominger	Peptide 15-mers of defined sequence that substitute for random amino acid copolymers in amelioration of experimental autoimmune encephalomyelitis.
000503 (2007)	Margaret C. Hsu [États-Unis] ; Jinhwa Lee ; Yoshito Kishi	Synthetic 3-O-methylmannose-containing polysaccharides (sMMPs): design and synthesis.
000534 (2007)	Jean-Yves Springael [Belgique] ; Eneko Urizar ; Sabine Costagliola ; Gilbert Vassart ; Marc Parmentier	Allosteric properties of G protein-coupled receptor oligomers.
000566 (2007)	Ravi Hegde [Israël] ; Gadi Borkow ; Alexander Berchanski ; Aviva Lapidot	Structure-function relationship of novel X4 HIV-1 entry inhibitors - L- and D-arginine peptide-aminoglycoside conjugates.
000602 (2008)	James Thurmond [États-Unis] ; Hyejin Yoon ; Carla Kuiken ; Karina Yusim ; Simon Perkins ; James Theiler ; Tanmoy Bhattacharya ; Bette Korber ; Will Fischer	Web-based design and evaluation of T-cell vaccine candidates.
000C28 (2013)	Nan Zhou ; Yun Zhang ; Jin-Chun Zhang ; Ling Feng ; Jin-Ku Bao	The receptor binding domain of MERS-CoV: The dawn of vaccine and treatment development
000E40 (2014)	Rolf Hilgenfeld	From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design
001133 (2015)	Hannah L. Peters [États-Unis] ; Dirk Jochmans [Belgique] ; Adriaan H. De Wilde [Pays-Bas] ; Clara C. Posthuma [Pays-Bas] ; Eric J. Snijder [Pays-Bas] ; Johan Neyts [Belgique] ; Katherine L. Seley-Radtke [États-Unis]	Design, synthesis and evaluation of a series of acyclic fleximer nucleoside analogues with anti-coronavirus activity.
001181 (2015)	Thingsoon Jong [Royaume-Uni] ; Ana M. Pérez-L Pez [Royaume-Uni] ; Emma M V. Johansson [Royaume-Uni] ; Annamaria Lilienkampf [Royaume-Uni] ; Mark Bradley [Royaume-Uni]	Flow and Microwave-Assisted Synthesis of N-(Triethylene glycol)glycine Oligomers and Their Remarkable Cellular Transporter Activities.
001413 (2015)	Michael Berry [Afrique du Sud] ; Burtram C. Fielding [Afrique du Sud] ; Junaid Gamieldien	Potential Broad Spectrum Inhibitors of the Coronavirus 3CLpro: A Virtual Screening and Structure-Based Drug Design Study
001517 (2016)	Fenghua Wang [République populaire de Chine] ; Cheng Chen [République populaire de Chine] ; Wenjie Tan [République populaire de Chine] ; Kailin Yang [États-Unis] ; Haitao Yang [République populaire de Chine]	Structure of Main Protease from Human Coronavirus NL63: Insights for Wide Spectrum Anti-Coronavirus Drug Design
001622 (2015)	Shuai Xia ; Qian Wang ; Shu-Wen Liu ; Lu Lu ; Shi-Bo Jiang	[Development of peptidic MERS-CoV entry inhibitors].
001623 (2015)	Xiao-Yun Zeng ; Lu Lu ; Shi-Bo Jiang ; Shu-Wen Liu	[Small molecular agents against MERS-CoV infection].
001824 (2017)	Shan Su [République populaire de Chine] ; Yun Zhu [République populaire de Chine] ; Sheng Ye [République populaire de Chine] ; Qianqian Qi [République populaire de Chine] ; Shuai Xia [République populaire de Chine] ; Zhenxuan Ma [République populaire de Chine] ; Fei Yu [République populaire de Chine] ; Qian Wang [République populaire de Chine] ; Rongguang Zhang [République populaire de Chine] ; Shibo Jiang [République populaire de Chine] ; Lu Lu [République populaire de Chine]	Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.
001879 (2017)	Lanying Du [États-Unis] ; Yang Yang [États-Unis] ; Yusen Zhou [République populaire de Chine] ; Lu Lu [République populaire de Chine] ; Fang Li [États-Unis] ; Shibo Jiang [États-Unis]	MERS-CoV spike protein: a key target for antivirals.
001911 (2017)	Jozlyn R. Clasman [États-Unis] ; Yahira M. Báez-Santos [États-Unis] ; Robert C. Mettelman [États-Unis] ; Amornrat O Rien [États-Unis] ; Susan C. Baker [États-Unis] ; Andrew D. Mesecar [États-Unis]	X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility for structure-based drug design

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Drug Design" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Drug Design" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Drug Design
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021